4-Methyl-1,3-Thiazole-2-Carboxylic Acid

In the synthesis of 2,4-disubstituted thiazole pharmacophores for kinase inhibitors, 4-methyl-1,3-thiazole-2-carboxylic acid functions as a versatile building block where the carboxylic acid moiety enables activation via acyl chloride or mixed anhydride formation prior to coupling with primary amines or heterocyclic nucleophiles. The acid is typically dissolved in anhydrous toluene (≤0.005% H₂O by Karl Fischer) and treated with thionyl chloride at a mole ratio of 1:1.08 in a 2000 L glass-lined reactor equipped with a condenser and caustic scrubber; the addition is controlled to maintain an internal temperature of 55–60°C and the reaction is aged under nitrogen until gas evolution ceases. After vacuum stripping of excess reagent, the resulting 4-methyl-1,3-thiazole-2-carbonyl chloride is coupled to N-Boc-piperazine in a Schotten-Baumann protocol using aqueous sodium bicarbonate to maintain pH 7.5–8.0, while a temperature probe with cascade control modulates jacket cooling to hold 0–5°C. Phase separation is monitored by an in-line turbidity meter; the organic layer is washed, dried over molecular sieves, and concentrated. The crude amide is crystallized from ethanol/water (70:30 v/v), isolated on a bottom-discharge centrifuge, and dried in a vacuum tray dryer at 45°C for 12 h. The isolated intermediate typically meets a purity specification of ≥99.5% (HPLC, area % at 210 nm, USP <621>), with residual solvents controlled per ICH Q3C options, single unknown impurity <0.10%, and palladium <10 ppm (when a prior Suzuki step is used upstream). This intermediate advances to a deprotection and subsequent reductive amination to yield the final active pharmaceutical ingredient, a candidate anaplastic lymphoma kinase inhibitor. Critical process parameters are documented in a master batch record under 21 CFR 211; full traceability of the heterocyclic acid lot, including its water content and sulfated ash, is mandatory to avoid out-of-specification coupling yields.

An Agrochemical Intermediate Where Controlled-Release Formulations Impact Field Efficacy

N-(2,6-dichlorophenyl)-4-methylthiazole-2-carboxamide, a systemic fungicide with oomycete activity, is prepared by acylating 2,6-dichloroaniline with the corresponding acid chloride in dichloromethane at –5 to 0°C, using triethylamine (1.05 eq) as acid scavenger. Post-reaction, the mixture is quenched with dilute HCl, the organic phase is distilled under reduced pressure, and the residue is recrystallized from isopropanol to achieve a technical purity of ≥98.0% (CIPAC MT 46, HPLC-UV). The technical material is then formulated as a 500 g/L suspension concentrate (SC) by wet bead milling in a horizontal media mill with 0.8–1.2 mm yttria-stabilized zirconia beads; the required particle size D₉₀ <5 µm is confirmed by laser diffraction (ISO 13320:2020). The milling base contains an EO-PO block copolymer dispersant (4.0% w/w), a naphthalene sulfonate wetter (1.5%), propylene glycol antifreeze (8.0%), and a polysaccharide thickener for in-can stability. A 14-day accelerated storage test at 54°C (CIPAC MT 46.3) must demonstrate viscosity below 800 mPa·s (Brookfield RVT, spindle #3, 20 rpm) and suspensibility >b>90% to pass FAO specification 572/TC. The formulated fungicide is applied via drip irrigation or foliar spray at rates between 200–400 g a.i./ha; compatibility with common organic fertilizers is verified in a jar test to avoid nozzle clogging in the field. The regulatory data package requires a five-batch analysis of the technical grade, a validated primary standard, and long-term stability data under 25°C/60% RH (zone II).

The calcium and zinc soaps of 4-methylthiazole-2-carboxylic acid have been evaluated as auxiliary heat stabilizers in flexible PVC compounds where the replacement of lead and organotin stabilizers is mandated by EU Directive 2011/65/EU (RoHS Recast). Pre-dispersion of the zinc salt in diisodecyl phthalate at a 40:60 ratio by weight is accomplished in a high-shear mixer at 80°C to avoid hydrate formation from residual moisture; this masterbatch is then blended with PVC resin (K-value 70), epoxidized soybean oil (5.0 phr), calcium stearate (0.8 phr), and the thiazole-based zinc salt at 0.5–1.2 phr in a Henschel mixer heated by friction to 120°C. The dry blend is subsequently compounded on a co-rotating twin-screw extruder (L/D 44:1, screw diameter 32 mm) with a temperature profile from 160°C (feed zone) to 190°C (die). Thermal stability is quantified by the Congo red test (DIN 53381) where the time to pH colour change must exceed 45 min at 200°C; the thiazole stabiliser works synergistically with epoxidized soybean oil to delay dehydrochlorination, retarding auto-catalytic degradation. Extractable Zn migration into aqueous food simulants (3% acetic acid, 40°C, 10 days) is kept below the specific migration limit of 5 mg/kg food (EU 10/2011) when the thiazole carboxylate dose remains below 1.0 phr. Residual free acid in the stabilizer must be controlled to ≤0.5% because it accelerates plate-out on the calibrator and die lip; this is monitored by acid–base titration in isopropanol against 0.1 N sodium hydroxide using a potentiometric endpoint. The final finished article—translucent medical tubing or wire and cable jacketing—passes UV-visible light transmission criteria of >80% at 550 nm after QUV weathering per ASTM G154.

Where the Ligand Geometry of 4-Methylthiazole-2-Carboxylate Dictates Cu/Fe Selectivity in Solvent Extraction

The direct esterification of the acid with 2-ethylhexanol (molar ratio 1:1.15, catalyst 0.2% p-toluenesulfonic acid, azeotropic water removal at 110–115°C under 300 mbar) yields a lipophilic ester that serves as a precursor to an N-alkyl hydroxamic acid extractant. After conversion with hydroxylamine hydrochloride under anhydrous conditions, the extractant is dissolved in a high-flash-point aliphatic diluent (ShellSol D70) at 0.10–0.15 M and conditioned with 2 M sulphuric acid. Continuous counter-current extraction trials in a 6-stage mixer-settler battery at an aqueous-to-organic flow ratio of 1.5:1 demonstrate that copper loading exceeds 7.0 g/L Cu²⁺ at pH 2.2, while iron co-extraction remains below 0.3 g/L. Stripping is accomplished with spent electrolyte containing 180 g/L H₂SO₄ and 30 g/L Cu at 40°C; phase disengagement times are routinely <90 s, and crud formation at the interface is negligible when the feed solution contains <15 mg/L colloidal silica. The extractant’s selectivity order, Cu²⁺ > Zn²⁺ > Ni²⁺ > Co²⁺, makes it suitable for upgrading pregnant leach solution from low-grade oxide ores ahead of electrowinning. A ligand-loss monitoring programme using gas chromatography–flame ionisation detection (GC-FID) with an internal standard quantifies extractant depletion at 0.8–1.4 mg per litre of raffinate, which is replenished inline via a dosing pump. The final cathode production, completed under ICMM sustainability benchmarks, must reach LME Grade A copper, while the raffinate boron and chloride limits are maintained below plant-specific thresholds to protect downstream solvent-extraction circuit integrity.

When 4-Methylthiazole Is Preferred Over Oxazole in Peptidomimetic Serine Protease Inhibitors

Insertion of the thiazole heterocycle as a bioisostere for a peptide bond exploits the lower basicity of the thiazole nitrogen relative to oxazole, thereby improving passive membrane permeability while retaining hydrogen-bond acceptor capacity. Solid-phase synthesis on chlorotrityl chloride resin begins with Fmoc-deprotection and swelling in DMF; the carboxylic acid of 4-methylthiazole-2-carboxylic acid is activated with HBTU (3.95 eq) and DIEA (6.0 eq) in anhydrous DMF at 0°C and coupled to the resin-bound P1 glycine for 120 min. The Kaiser test is negative after a double coupling cycle. Following chain elongation with fluorenylmethyloxycarbonyl-protected amino acids, cleavage from the resin with 2% TFA in dichloromethane retains side-chain protecting groups, and the C-terminal carboxylate is then reduced to the aldehyde with oxalyl chloride/DMSO/TEA (Swern conditions, –60°C) to yield the crucial electrophilic trap for the catalytic serine. Preparative HPLC on a C18 column (gradient 20–80% acetonitrile in 0.1% aqueous TFA) yields the final peptidomimetic with >98% purity; mass confirmation is by ESI-MS. In an enzymatic assay against factor Xa, the compound exhibits a competitive inhibition constant (Kᵢ) of 12 nM in Tris-HCl buffer pH 7.4 containing 200 mM NaCl and 0.01% Triton X-100 at 37°C. All synthesis steps are documented in a laboratory notebook compliant with ICH Q7 and can be tech-transferred to a pilot plant equipped with a fume-hood-contained peptide synthesizer (20 mmol scale) and a lyophilizer with a condenser temperature of –85°C. Stability of the freeze-dried powder is monitored by HPLC at –20°C and 25°C/60% RH; degradation above 5% total impurities after 6 months triggers a re-qualification of the primary reference standard.

Derivatization of the carboxylic acid to a sulfonamide-based fluorescent probe for cysteine detection in aqueous buffers exploits the thiazole ring’s modest fluorescence quantum yield. The acid is reacted with thionyl chloride to regenerate the acyl chloride, which is then added dropwise to a chilled solution of 1,2-diaminoanthraquinone (1.0 eq) in anhydrous N-methyl-2-pyrrolidone containing 1.5 eq of N,N-diisopropylethylamine; the addition must be completed over 45 min at –10°C to minimise di-substitution. After overnight stirring at ambient temperature, the crude quinone conjugate is purified on a silica gel column (200–300 mesh) eluting with n-hexane:ethyl acetate (1:1, Rf 0.35). The purified probe is then formulated as a 10 mM DMSO stock solution and stored over molecular sieves. In a HEPES buffer assay at pH 7.2, the probe (10 µM) exhibits a >b>45-fold fluorescence turn-on at 540 nm (excitation 470 nm) upon addition of 100 µM L-cysteine, with a limit of detection of 0.8 µM (S/N >b>3). The reaction mechanism involves Michael addition of the thiol to the quinone, followed by cleavage of the sulfonamide bond and restoration of the fluorophore. Interference from homocysteine and glutathione is minimal at physiological ratios when the incubation time is limited to 15 min. For routine use in a contract research laboratory setting, the probe is lyophilized in amber vials under sterile conditions and accompanied by a certificate of analysis that reports purity by two methods (HPLC-UV at 254 nm and ¹H NMR). While not subject to pharmacopoeial monograph control, the batch release testing follows a schema aligned with ISO 9001:2015, and residual DMSO concentration in the final lyophilized powder is kept below 500 ppm by gas chromatography headspace analysis. The compound is shipped as a research-use-only tool and is labelled accordingly; any deviation in the melting point window of 122–125°C (capillary, open tube) triggers a full out-of-specification investigation in the QMS.